Drugs / Inactivated Influenza Vaccine (Split Virion)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01465035 Comparator | Oct 2011 → Nov 2012 | influenza | University of Oxford | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Influenza Vaccine (Split Virion) | “Inactivated Influenza Vaccine (Split Virion) 0.5ml (containing 15 micrograms of haemagglutinin” NCT01465035 ↗ |
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01465035 ↗ |
| Modality | Vaccine | “seasonal influenza vaccine (TIV)” NCT01465035 ↗ |
| Route | Intramuscular | “Inactivated Influenza Vaccine (Split Virion) 0.5ml (containing 15 micrograms of haemagglutinin, intramuscular injection into the thigh” NCT01465035 ↗ |